StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > The only answer is

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Sep 05, 2021 10:09pm

149 Views

Post# 33816108

RE:RE:RE:The only answer is

Exactly. If it was such a bad investment there would be no interest and no posts. Just the fact they try so hard and spend hours on here is proof enough

The company has turned the corner let them execute. It's obvious they have an ax to grind and are members of the short and distort team. More reason than ever to buy at this low level